Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessHighly AccessResearch

Effect of rosuvastatin on outcomes in chronic haemodialysis patients – design and rationale of the AURORA study

Bengt Fellström1 email, Faiez Zannad2 email, Roland Schmieder3 email, Hallvard Holdaas4 email, Alan Jardine5 email, Helen Rose6 email and Wim Wilpshaar7 email for the AURORA Study Group

1Department of Medical Science, Renal Unit, University Hospital, Uppsala, Sweden

2Clinical Investigation Center INSERM (CIC), Hôpital Jeanne d'Arc, Toul, France

3Med Klinik IV, Univ.-Klinik Erlangen-Nürnberg, Germany

4Department of Nephrology, Rikshospitalet, Oslo, Norway

5Department of Medicine and Therapeutics, Western Infirmary Hospital, Glasgow, United Kingdom

6AstraZeneca, Macclesfield, United Kingdom

7AstraZeneca, Macclesfield, United Kingdom

author email corresponding author email

Current Controlled Trials in Cardiovascular Medicine 2005, 6:9doi:10.1186/1468-6708-6-9

Published: 23 May 2005

Additional files

Additional File 1:

Table 2. study plan (includes table footnotes)

Format: PDF Size: 57KB Download file

This file can be viewed with: Adobe Acrobat Reader

© 1999-2008 BioMed Central Ltd unless otherwise stated < info@biomedcentral.com >   Terms and conditions